Jump to navigation
Donate
Client-reported quality of facility-managed medication abortion compared with pharmacy-sourced self-managed abortion in Bangladesh
Effectiveness of self-managed medication abortion between 9 and 16 weeks of gestation
Effectiveness of medication abortion with misoprostol alone in the SAFE study: A prospective observational cohort study
"The first difficulty is time:" The impact of gestational age limits on reproductive health and justice in the context of cross-border travel for abortion care in Europe
French women’s experiences and opinions with in-country versus cross-border abortion travel: A mixed-methods paper
Accounting for misclassification and selection bias in estimating effectiveness of self-managed medication abortion
A qualitative exploration of how the COVID-19 pandemic shaped experiences of self-managed medication abortion with accompaniment group support in Argentina, Indonesia, Nigeria, and Venezuela
Inter-departmental abortion travels in metropolitan France: A mixed-methods analysis of women’s experiences, access, and barriers to abortion care
Beyond safety: The 2022 WHO abortion guidelines and the future of abortion safety measurement
Overcoming challenges in research on self-managed medication abortion: Lessons from a collaborative activist–researcher partnership
